| Tretinoin | Approved Investigational Nutraceutical | CLIP2 | 7461 |
upregulated | Tretinoin results in increased expression of CLIP2 mRNA | 7q11.23 | |
| Tretinoin | Approved Investigational Nutraceutical | CLIP4 | 79745 |
upregulated | Tretinoin results in increased expression of CLIP4 mRNA | 2p23.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CLMN | 79789 |
downregulated | Tretinoin results in decreased expression of CLMN mRNA | 14q32.13 | |
| Tretinoin | Approved Investigational Nutraceutical | CLMN | 79789 |
upregulated | Tretinoin results in increased expression of CLMN mRNA | 14q32.13 | |
| Tretinoin | Approved Investigational Nutraceutical | CLSTN3 | 9746 |
upregulated | Tretinoin results in increased expression of CLSTN3 mRNA | 12p13.31 | |
| Tretinoin | Approved Investigational Nutraceutical | CLTB | 1212 |
upregulated | Tretinoin results in increased expression of CLTB mRNA | 5q35.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CLU | 1191 |
downregulated | Tretinoin results in decreased expression of CLU mRNA | 8p21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CLU | 1191 |
upregulated | Tretinoin results in increased expression of CLU mRNA | 8p21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CMAS | 55907 |
downregulated | Tretinoin results in decreased expression of CMAS mRNA | 12p12.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CMC2 | 56942 |
upregulated | Tretinoin results in increased expression of CMC2 mRNA | 16q23.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CMTM6 | 54918 |
upregulated | Tretinoin results in increased expression of CMTM6 mRNA | 3p22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CMTM7 | 112616 |
downregulated | Tretinoin results in decreased expression of CMTM7 mRNA | 3p22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CNBP | 7555 |
downregulated | Tretinoin results in decreased expression of CNBP mRNA | 3q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CNDP1 | 84735 |
upregulated | Tretinoin results in increased expression of CNDP1 mRNA | 18q22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CNGA1 | 1259 |
upregulated | Tretinoin results in increased expression of CNGA1 mRNA | 4p12 | |
| Tretinoin | Approved Investigational Nutraceutical | CNIH4 | 29097 |
downregulated | Tretinoin results in decreased expression of CNIH4 mRNA | 1q42.11 | |
| Tretinoin | Approved Investigational Nutraceutical | CNKSR2 | 22866 |
downregulated | Tretinoin results in decreased expression of CNKSR2 mRNA | Xp22.12 | |
| Tretinoin | Approved Investigational Nutraceutical | CNKSR3 | 154043 |
downregulated | Tretinoin results in decreased expression of CNKSR3 mRNA | 6q25.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CNKSR3 | 154043 |
upregulated | Tretinoin results in increased expression of CNKSR3 mRNA | 6q25.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CNN1 | 1264 |
upregulated | Tretinoin results in increased expression of CNN1 mRNA | 19p13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CNN2 | 1265 |
upregulated | Tretinoin results in increased expression of CNN2 mRNA | 19p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CNNM2 | 54805 |
upregulated | Tretinoin results in increased expression of CNNM2 mRNA | 10q24.32 | |
| Tretinoin | Approved Investigational Nutraceutical | CNP | 1267 |
upregulated | Tretinoin results in increased expression of CNP mRNA | 17q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CNPY2 | 10330 |
upregulated | Tretinoin results in increased expression of CNPY2 mRNA | 12q13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CNR1 | 1268 |
upregulated | Tretinoin results in increased expression of CNR1 mRNA | 6q15 | |